全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1874218-36-6 | 3-氟-alpha-[1-[(2-羟基乙基)氨基]乙基]苯甲醇 | C11H16FNO2 |
| 1874276-76-2 | 3-氨基-N-[3-(4-氨基-4-甲基哌啶-1-基)吡啶-2-基]-6-[3-(三氟甲基)吡啶-2-基]吡嗪-2-甲酰胺 | C22H23F3N8O |
| 1875153-79-9 | POM单酯化甲基阿德福韦 | C15H24N5O6P |
| 1876467-74-1 | 2-[(3R)-3-甲基-4-吗啉基]-4-(1-甲基-1H-吡唑-5-基)-8-(1H-吡唑-3-基)-1,7-萘啶 | C20H21N7O |
| 1878105-23-7 | N-XantPhos 钯 G4 | C50H43N2O4P2PdS- |
| 1878109-35-3 | 2-[(2-羟基环戊基)氧基羰基氨基]-3,3-二甲基丁酸 | C12H21NO5 |
| 1878111-20-6 | 2-丁氧基-7-[[4-(1-吡咯烷基甲基)苯基]甲基]-5H-吡咯并[3,2-d]嘧啶-4-胺 | C22H29N5O |
| 1879009-96-7 | 蛋氨酸杂质1 | C12H22N2O4S2 |
| 1879903-65-7 | 利伐沙班氧代胺酰胺杂质 | C19H18ClN3O5S |
| 1882075-20-8 | (11bS)-4-羟基-2,6-二(2,3,4,5,6-五氟苯基)-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物 | C32H11F10O4P |
| 1882095-50-2 | 2-(((3aR,4S,6R,6aS)-6-((6-(((3aS,4R,6S,6aS)-6-(2-羟基乙氧基)-2,2-二甲基四氢-3aH-环戊二烯并[d][1,3]二氧杂环戊烯-4-基)氨基)-5-硝基-2-(丙硫基)嘧啶-4-基)氨基)-2,2-二甲基四氢-3aH-环戊二烯并[d][1,3]二氧杂环戊烯-4-基)氧基)乙醇 | C27H43N5O10S |
| 1882095-51-3 | 2-(((3aS,4S,6R,6aS)-6-((5-氨基-6-(((3aS,4R,6S,6aR)-6-(2-羟基乙氧基)-2,2-二甲基四氢-3aH-环戊二烯并[d][1,3]二氧杂环戊烯-4-基)氨基)-2-(丙硫基)嘧啶-4-基)氨基)-2,2-二甲基四氢-3aH-环戊二烯并[d][1,3]二氧杂环戊烯-4-基)氧基)乙醇 | C27H45N5O8S |
| 1882873-21-3 | 乐伐替尼杂质16 | C21H17ClN4O3 |
| 1883265-32-4 | 2-氯-4-(1-二苯并呋喃基)-6-苯基-1,3,5-三嗪 | C21H12ClN3O |
| 1883265-36-8 | 2-([1,1'-联苯]-3-基)-4-氯-6-(二苯并[b,d]呋喃-1-基)-1,3,5-三嗪 | C27H16ClN3O |
| 1883284-94-3 | 1-[(4-氟苯基)甲基]-1H-吲哚-3-羧酸 1-萘基酯 | C26H18FNO2 |
| 1883299-62-4 | 布雷泊西替尼 | C18H21F2N7O |
| 1883377-30-7 | 8-[4-(2,2-二甲基丙基)-2-吡啶基]-2-(甲基)-苯并呋喃并[2,3-b]吡啶 | C22H22N2O |
| 1883423-59-3 | [(2S)-2-(4-氯苯基)-1-吡咯烷基](3-甲基-1H-吡唑并[3,4-b]吡啶-5-基)甲酮 | C18H17ClN4O |
| 1883429-22-8 | 4-(4-((二甲基氨基)甲基)-2,5-二甲氧基苯基)-2-甲基-2,7-萘啶-1(2H)-酮 | C20H23N3O3 |
| 1883548-89-7 | NI 57 | C19H17N3O4S |
| 1883563-86-7 | 替诺福韦相关化合物8 | C22H40N7O6P |
| 1883595-37-6 | 5-(2-氟苯基)-1-(3-吡啶基磺酰基)-1H-吡咯-3-羧酸 | C16H11FN2O4S |
| 1883595-38-7 | 5-(2-氟苯基)-1H-吡咯-3-羧酸 | C11H8FNO2 |
| 1883595-39-8 | 5-(2-氟苯基)-N-甲基-1-(3-吡啶基磺酰基)-1H-吡咯-3-甲亚胺 N-氧化物 | C17H14FN3O3S |
| 1883672-48-7 | 哌柏西利杂质 B 盐酸盐 | C29H38ClN7O4 |
| 1883681-10-4 | 阿齐沙坦杂质21 | C29H26N4O7 |
| 1884139-61-0 | (Z)-帕立骨化醇 | C27H44O3 |
| 1884269-07-1 | Sacubitril-[d4] | C24H25D4NO5 |
| 1884279-18-8 | 4-(5-甲基-3-苯基-4-异恶唑基)苯磺酸乙基酯 | C18H17NO4S |
| 1884576-18-4 | 2-乙基丁基(2S)-2-[[[(3aR,4R,6R,6aR)-4-(4-氨基吡咯并[2,1-f][1,2,4]三嗪-7-基)-4-氰基-2,2-二甲基-6,6a-二氢-3aH-呋喃并[3,4-d][1,3]二氧杂环戊烯-6-基]甲氧基-苯氧基磷酰]氨基]丙酸酯 | C30H39N6O8P |
| 1884646-78-9 | CPI 410S | |
| 1884712-47-3 | CPI-637 | C22H22N6O |
| 1885094-62-1 | 5-(2-氟苯基)-N,N-二甲基-1-(3-吡啶基磺酰基)-1H-吡咯-3-甲胺 | C18H18FN3O2S |
| 1886961-39-2 | 2-(3-氰基-4-乙氧基苯基)-4-甲基-5-噻唑羧酸 | C14H12N2O3S |
| 1886994-07-5 | 3-溴-1H-吡唑-5-羧酸乙酯 | C6H7BrN2O2 |
| 1887009-48-4 | (S)-3-(1-氨基乙基)-6-氯喹啉-2(1H)-酮盐酸盐 | C11H12Cl2N2O |
| 1887009-51-9 | (R)-3-(1-氨乙基)-6-氯喹啉-2(1H)-酮盐酸盐 | C11H12Cl2N2O |
| 1887014-12-1 | Olutasidenib | C18H15ClN4O2 |
| 1887015-55-5 | 5-氟-1-甲基-6-氧代-1,6-二氢吡啶-2-甲腈 | C7H5FN2O |
| 1887057-05-7 | 多西他赛 EP 杂质A | C41H55NO14 |
| 1887095-82-0 | 42-O-[2-[[1-[32-[4-氨基-3-(2-氨基-5-苯并恶唑基)-1H-吡唑并[3,4-d]嘧啶-1-基]-27-氧代-3,6,9,12,15,18,21,24-八氧杂-28-氮杂三十二烷-1-基]-1H-1,2,3-三唑-4-基]甲氧基]乙基]雷帕霉素 | C91H138N12O24 |
| 1887197-42-3 | 2-[(1S,2S)-1-乙基-2-(苯基甲氧基)丙基]肼甲醛草酸盐 | C13H20N2O2.C2H2O4 |
| 1887742-42-8 | 阿德保宁代谢物 M3 | C14H18N4O2 |
| 1888294-91-4 | 2,3,4,5-四氢-1-[2-甲基-4-(3-甲基-1H-吡唑-1-基)苯甲酰基]-5-氧代-1H-1-苯并氮杂卓-4-羧酸乙酯 | C25H25N3O4 |
| 1888419-06-4 | 6-[2-(三氟甲基)-5-嘧啶基]-2-吡啶胺 | C10H7F3N4 |
| 1888438-11-6 | 9-([1,1'-联苯]-4-基)-9'-(苯并菲-2-基)-9H,9'H-3,3'-联咔唑 | C54H34N2 |
| 1888438-12-7 | 9-[1,1'-联苯]-3-基-9'-(2-苯并菲基)-3,3'-联-9H-咔唑 | C54H34N2 |
| 1888902-20-2 | 4-氯-7-异喹啉醇 | C9H6ClNO |
| 1889279-16-6 | A-485 | C25H24F4N4O5 |